19/01/2026
What This Research Shows
Osteoarthritis (OA) affects millions of people worldwide and causes progressive joint damage, pain, inflammation, and loss of mobility. While current treatments like medications and surgery can help manage symptoms, they often come with side effects and don't stop the disease from progressing.
Recent research published in Biomedical Pharmacotherapy demonstrates that mesenchymal stem cells (MSCs) offer a promising regenerative approach to treating osteoarthritis by addressing the root causes of joint deterioration rather than just masking symptoms.
How MSCs Work to Treat Osteoarthritis
MSCs are specialized cells that can transform into different types of tissue, including cartilage. When injected into the knee joint, they work through four main pathways:
1. Regenerating Damaged Tissue
MSCs can differentiate into healthy chondrocytes (cartilage cells) and synoviocytes (cells that line the joint), replacing damaged cells and helping rebuild protective cushioning in your joints.
2. Protecting Existing Cartilage
Rather than allowing the the structural framework of cartilage to continue breaking down, MSCs help prevent further degradation and support cartilage repair.
3. Reducing Inflammation
Chronic inflammation driven by immune cells called macrophages is a major contributor to OA progression. MSCs calm this inflammation, reducing joint swelling and protecting remaining healthy tissue from damage.
4. Relieving Pain
By addressing inflammation and supporting tissue repair, MSCs have been shown to significantly reduce pain levels and improve joint function, allowing patients to move more comfortably.
What This Means for You
Research demonstrates that MSC therapy offers a multi-faceted approach to osteoarthritis treatment. Rather than managing pain temporarily, this regenerative therapy targets the underlying causes of joint degeneration. Clinical studies show improvements in pain levels, joint function, and quality of life, as well as safety.
At Alevy, we utilize these evidence-based principles in our stem cell protocols, offering high-dosage treatments from our ISO-certified laboratory to maximize therapeutic potential for our patients.